Sign In

Login

Password

Forgot Password ? Sign Up

PROTAC (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "PROTAC" in German language version.

refsWebsite
Global rank German rank
16doi.org
2nd place
3rd place
1nih.gov
4th place
7th place
1nhregister.com
6,740th place
low place
1bostonglobe.com
553rd place
2,253rd place

bostonglobe.com

doi.org

  • M. Ishoey, S. Chorn, N. Singh, M. G. Jaeger, M. Brand, J. Paulk, S. Bauer, M. A. Erb, K. Parapatics, A. C. Müller, K. L. Bennett, G. F. Ecker, J. E. Bradner, G. E. Winter: Translation Termination Factor GSPT1 is a Phenotypically Relevant Off-Target of Heterobifunctional Phthalimide Degraders. In: ACS Chemical Biology. Band 13, Nr. 3, 2018, S. 553–560, doi:10.1021/acschembio.7b00969.
  • Vladas Oleinikovas, Pablo Gainza, Thomas Ryckmans, Bernhard Fasching, Nicolas H. Thomä: From Thalidomide to Rational Molecular Glue Design for Targeted Protein Degradation. In: Annual Review of Pharmacology and Toxicology. Band 64, 23. Januar 2024, S. 291–312, doi:10.1146/annurev-pharmtox-022123-104147, PMID 37585660.
  • Katerina Cermakova, H. Hodges: Next-Generation Drugs and Probes for Chromatin Biology: From Targeted Protein Degradation to Phase Separation. In: Molecules. Band 23, Nr. 8, 6. August 2018, S. 1958, doi:10.3390/molecules23081958 (26 S.).
  • Kathleen M. Sakamoto, Kyung B. Kim, Akiko Kumagai, Frank Mercurio, Craig M. Crews, Raymond J. Deshaies: Protacs: Chimeric molecules that target proteins to the Skp1–Cullin–F box complex for ubiquitination and degradation. In: Proceedings of the National Academy of Sciences. Band 98, Nr. 15, 17. Juli 2001, S. 8554–8559, doi:10.1073/pnas.141230798.
  • Kelly Rae Chi: Drug developers delve into the cell's trash-disposal machinery. In: Nature Reviews Drug Discovery. Band 15, Nr. 5, Mai 2016, S. 295–297, doi:10.1038/nrd.2016.86.
  • Michael Zengerle, Kwok-Ho Chan, Alessio Ciulli: Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4. In: ACS Chemical Biology. Band 10, Nr. 8, 21. August 2015, S. 1770–1777, doi:10.1021/acschembio.5b00216.
  • Bondeson DP, Mares A, Smith IE, Ko E, Campos S, Miah AH, Mulholland KE, Routly N, Buckley DL, Gustafson JL, Zinn N, Grandi P, Shimamura S, Bergamini G, Faelth-Savitski M, Bantscheff M, Cox C, Gordon DA, Willard RR, Flanagan JJ, Casillas LN, Votta BJ, den Besten W, Famm K, Kruidenier L, Carter PS, Harling JD, Churcher I, Crews CM: Catalytic in vivo protein knockdown by small-molecule PROTACs. In: Nature Chemical Biology. 11. Jahrgang, Nr. 8, August 2015, S. 611–617, doi:10.1038/nchembio.1858.
  • Buckley DL, Raina K, Darricarrere N, Hines J, Gustafson JL, Smith IE, Miah AH, Harling JD, Crews CM: HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins. In: ACS Chemical Biology. 10. Jahrgang, Nr. 8, August 2015, S. 1831–7, doi:10.1021/acschembio.5b00442.
  • Lu J, Qian Y, Altieri M, Dong H, Wang J, Raina K, Hines J, Winkler JD, Crew AP, Coleman K, Crews CM: Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. In: Chemistry & Biology. 22. Jahrgang, Nr. 6, Juni 2015, S. 755–63, doi:10.1016/j.chembiol.2015.05.009.
  • Winter GE, Buckley DL, Paulk J, Roberts JM, Souza A, Dhe-Paganon S, Bradner JE: DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation. In: Science. 348. Jahrgang, Nr. 6241, Juni 2015, S. 1376–81, doi:10.1126/science.aab1433.
  • Schneekloth AR, Pucheault M, Tae HS, Crews CM: Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics. In: Bioorganic & Medicinal Chemistry Letters. 18. Jahrgang, Nr. 22, November 2008, S. 5904–8, doi:10.1016/j.bmcl.2008.07.114.
  • Alberto Ocaña, Atanasio Pandiella: Proteolysis targeting chimeras (PROTACs) in cancer therapy. In: Journal of Experimental & Clinical Cancer Research. 39. Jahrgang, Nr. 1, 15. September 2020, S. 189, doi:10.1186/s13046-020-01672-1.
  • Itoh Y, Kitaguchi R, Ishikawa M, Naito M, Hashimoto Y: Design, synthesis and biological evaluation of nuclear receptor-degradation inducers. In: Bioorganic & Medicinal Chemistry. 19. Jahrgang, Nr. 22, November 2011, S. 6768–78, doi:10.1016/j.bmc.2011.09.041.
  • Melanie Schneider, Chris J. Radoux, Andrew Hercules, David Ochoa, Ian Dunham, Lykourgos-Panagiotis Zalmas, Gerhard Hessler, Sven Ruf, Veerabahu Shanmugasundaram, Michael M. Hann, Pam J. Thomas: The PROTACtable genome. In: Nature Reviews Drug Discovery. 20. Jahrgang, Nr. 10, Juli 2021, S. 789–797, doi:10.1038/s41573-021-00245-x.
  • Carlotta Cecchini, Sara Pannilunghi, Sébastien Tardy, Leonardo Scapozza: From Conception to Development: Investigating PROTACs Features for Improved Cell Permeability and Successful Protein Degradation. In: Frontiers in Chemistry. 9. Jahrgang, 2021, S. 672267, doi:10.3389/fchem.2021.672267.
  • Daniel P. Bondeson, Craig M. Crews: Targeted Protein Degradation by Small Molecules. In: Annual Review of Pharmacology and Toxicology. 57. Jahrgang, 6. Januar 2017, S. 107–123, doi:10.1146/annurev-pharmtox-010715-103507.

nhregister.com

nih.gov

ncbi.nlm.nih.gov

  • Vladas Oleinikovas, Pablo Gainza, Thomas Ryckmans, Bernhard Fasching, Nicolas H. Thomä: From Thalidomide to Rational Molecular Glue Design for Targeted Protein Degradation. In: Annual Review of Pharmacology and Toxicology. Band 64, 23. Januar 2024, S. 291–312, doi:10.1146/annurev-pharmtox-022123-104147, PMID 37585660.